Literature DB >> 23458649

Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.

Kinsey Lam1, Liang Zeng, Liying Zhang, Ling-Ming Tseng, Ming-Feng Hou, Alysa Fairchild, Vassilios Vassiliou, Reynaldo Jesus-Garcia, Mohamed A Alm El-Din, Aswin Kumar, Fabien Forges, Wei-Chu Chie, Arjun Sahgal, Michael Poon, Edward Chow.   

Abstract

OBJECTIVE: The European Organization of Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire - Core 15 Palliative (EORTC QLQ-C15-PAL) was developed to assess quality of life (QOL) for the palliative cancer population to decrease patient burden. The purpose of this study was to compare predictive factors for well-being in the QLQ-C15-PAL extracted from the EORTC Quality of Life Questionnaire - Core 30 (QLQ-C30) with the QLQ-C30 itself. METHODS AND MATERIALS: Patients with advanced cancer referred for treatment of bone metastases completed the QLQ-C30. Fifteen items from the QLQ-C15-PAL were extracted from the QLQ-C30. Univariate and multivariate analyses were used to determine predictive factors of the global QOL/health score in both tools. In the multivariate analyses, a p value of <0.003 indicated statistical significance.
RESULTS: Overall, predictive factors were similar when analyzing data from both tools. Predictive factors for the QLQ-C30 were role functioning (p<0.0001), fatigue (p<0.0001), nausea/vomiting (p<0.0001), and financial problems (p<0.0001) and factors for the extracted QLQ-C15-PAL were physical functioning (p<0.0001) and fatigue (p<0.0001).
CONCLUSIONS: Extraction of the QLQ-C15-PAL items from the QLQ-C30 resulted in similar predictive QOL domains for all patient subgroups analyzed individually. The QLQ-C15-PAL is reflective of the QLQ-C30 domains and is recommended for future studies involving patients in a palliative setting, as this shorter questionnaire reduces patient burden and may increase accrual and compliance, while maintaining a similar breadth of coverage and achieving the same predictive ability.

Entities:  

Mesh:

Year:  2013        PMID: 23458649     DOI: 10.1089/jpm.2012.0398

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  Quality of Life in Palliative Care.

Authors:  Mellar P Davis; David Hui
Journal:  Expert Rev Qual Life Cancer Care       Date:  2017-11-08

2.  Management of Metastatic Disease in Campania (MAMETIC): An Observational Multicenter Retrospective and Prospective Trial on Palliative Radiotherapy in an Italian Region. Study Protocol.

Authors:  Rossella Di Franco; Marco Cascella; Mario Fusco; Valentina Borzillo; Esmeralda Scipilliti; Piera Ferraioli; Eva Iannacone; Giampaolo De Palma; Giustino Silvestro; Federica Gherardi; Sergio Buonopane; Domingo Alberti; Giuseppe Totaro; Roberto Manzo; Giovanna Guida; Arturo Cuomo; Sandro Pignata; Marilena Di Napoli; Sabrina Rossetti; Egidio Celentano; Anna Crispo; Maria Grimaldi; Vincenzo Ravo; Paolo Muto
Journal:  J Pain Res       Date:  2022-04-08       Impact factor: 3.133

3.  Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.

Authors:  Francesco Cellini; Stefania Manfrida; Francesco Deodato; Savino Cilla; Ernesto Maranzano; Stefano Pergolizzi; Fabio Arcidiacono; Rossella Di Franco; Francesco Pastore; Matteo Muto; Valentina Borzillo; Costanza Maria Donati; Giambattista Siepe; Salvatore Parisi; Antonia Salatino; Antonino D'Agostino; Giampaolo Montesi; Anna Santacaterina; Vincenzo Fusco; Mario Santarelli; Maria Antonietta Gambacorta; Renzo Corvò; Alessio Giuseppe Morganti; Valeria Masiello; Paolo Muto; Vincenzo Valentini
Journal:  Trials       Date:  2019-10-28       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.